Puma Biotechnology Inc share price logo

Puma Biotechnology Inc Share Price

NASDAQ: PBYI

Small Cap

$7.58

+0.01

(+0.13%)

as on

Puma Biotechnology Inc Stock Performance

as on April 15, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $7.46
    $7.73
    downward going graph

    1.58%

    Downside

    1.98%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.75
    $7.90
    downward going graph

    63.72%

    Downside

    4.20%

    Upside

    downward going graph

Puma Biotechnology Inc share price movements today

Previous Close
$7.57
Open
$7.58
Volume
878.3K
Day's Low - High
$7.46 - $7.73
52 Week Low - High
$2.75 - $7.90

Puma Biotechnology Inc Historical Returns

1 Month Return
+ 28.31 %
3 Month Return
+ 17.91 %
1 Year Return
+ 158.36 %
3 Year Return
+ 150.66 %
5 Year Return
-25.71 %

Puma Biotechnology Inc Stock Fundamentals & Key Indicators

Check Puma Biotechnology Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$395.8M

EPS (TTM)

0.4

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.34%

PE Ratio (TTM)

12.75

Industry PE ratio

-4.399805825242718

PEG Ratio

0.03

EBITDA

47.4M

Revenue (TTM)

228.4M

Profit Margin

13.62%

Return On Equity TTM

27.97%

Puma Biotechnology Inc Stock Valuation

Track how Puma Biotechnology Inc P/E has moved over time to understand its valuation trends.

Puma Biotechnology Inc in the last 5 years

  • Overview

  • Trends

Lowest (-62.40x)

June 30, 2023

Industry (-4.40x)

April 14, 2026

Today (12.75x)

April 14, 2026

Highest (42.57x)

September 30, 2023

LowHigh

Today’s Price to Earnings Ratio: 12.75x

Puma Biotechnology Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Puma Biotechnology Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Puma Biotechnology Inc image
Puma Biotechnology Inc
SELL$395.8M-25.71%12.7513.62%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$42.7B140.76%138.848.45%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$111.0B102.67%28.532.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$35.6BNA124.865.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$79.2B55.14%18.0531.41%

Stock Returns calculator for Puma Biotechnology Inc Stock including INR - Dollar returns

The Puma Biotechnology Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Puma Biotechnology Inc investment value today

Current value as on today

₹2,79,849

Returns

₹1,79,849

(+179.85%)

Returns from Puma Biotechnology Inc Stock

₹1,58,703 (+158.7%)

Dollar Impact

₹21,146 (+21.15%)

Analyst Recommendation on Puma Biotechnology Inc Stock

Based on 8 analysts

SELL

12.50%

Buy

37.50%

Hold

50.00%

Sell

Based on 8 analysts, 50% of analysts recommend a 'SELL' rating for Puma Biotechnology Inc. Average target price of $5

Puma Biotechnology Inc Share Price Target

Get share price movements and forecasts by analysts on Puma Biotechnology Inc.

What analysts predicted

-51.6%DOWNSIDE

Target Price

$5

Current Price

$7.58

Analyzed by

8 Analysts

Target

$5.00

Puma Biotechnology Inc target price $5, a slight downside of -51.6% compared to current price of $7.58. According to 8 analysts rating.

Puma Biotechnology Inc Stock’s Investor Sentiment and Interest

Search interest for Puma Biotechnology Inc Stock has decreased by -43% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-43% versus previous 30 day period

Puma Biotechnology Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
56
72
43
47
80
59
46
52
54
75
Gross Profit
42
47
33
36
51
45
35
40
42
52
Operating Income
8
14
-2
-2
22
13
3
6
9
17
EBITDA
11
18
1
2
26
17
8
10
13
26
Interest Expense
3
3
3
3
3
2
2
1
1
1
Depreciation
2
2
2
2
2
2
2
2
2
2
Income Before Tax
6
12
-4
-4
20
12
3
6
9
17
Income Tax Expense
0
0
0
0
0
-7
0
0
0
3
Net Income
5
12
-4
-4
20
19
2
5
8
13
Net Profit Margin
10.33%
17.00%
-11.00%
-9.62%
25.23%
32.68%
6.46%
11.17%
16.23%
17.75%

Puma Biotechnology Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
27
251
272
225
253
228
235
230
228
Gross Profit
-1
22
216
235
185
189
172
172
166
170
Operating Income
-276
-292
-94
-75
-30
1
23
32
30
37
EBITDA
-275
-288
-95
-52
-35
-4
21
47
48
53
Interest Expense
0
0
11
15
14
12
11
13
12
6
Depreciation
-
2
7
8
10
10
8
10
11
10
Income Before Tax
-276
-292
-113
-75
-59
-28
0
22
24
35
Income Tax Expense
-2
-2
-7
0
0
0
0
1
-6
4
Net Income
-276
-292
-113
-75
-59
-29
0
21
30
31
Net Profit Margin
0.00%
-1054.15%
-45.26%
-27.77%
-26.65%
-11.51%
0.00%
9.16%
13.14%
13.62%

Puma Biotechnology Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
12
-4
-4
20
19
2
5
8
11
Operating Cash Flow
10
11
1
11
15
3
14
9
14
Investing Cash Flow
-8
-19
0
0
-2
1
-11
0
-26
Financing Cash Flow
-
-
-11
-11
-11
-11
-11
-11
-11
Change in Cash
2
-7
-9
0
1
-6
-8
-1
-23

Puma Biotechnology Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-291
-113
-75
-59
-29
0
21
30
31
Operating Cash Flow
-172
-24
22
0
20
-15
27
38
41
Investing Cash Flow
-15
-57
5
23
-10
7
-19
-20
-36
Financing Cash Flow
75
108
-67
0
-31
12
2
-33
-45
Change in Cash
-112
26
-39
24
-22
3
7
-15
-39

Global Institutional Holdings in Puma Biotechnology Inc

Funds
Holdings
Geode Capital Management, LLC
1.95%
Bank of New York Mellon Corp
0.68%
Charles Schwab Investment Management Inc
0.25%
BlackRock Inc
7.03%
Acadian Asset Management LLC
4.04%
See all

Insights on Puma Biotechnology Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, 2.97M → 13.4M (in $), with an average increase of 39.0% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, PBYI stock has moved up by 28.3%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, PBYI has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, PBYI has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 46.00M → 75.5M (in $), with an average increase of 14.6% per quarter

About Puma Biotechnology Inc

Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. It offers NERLYNX, an oral version of neratinib that is used to treat adult patients with early stage HER2-overexpressed/amplified breast cancer; and advanced or metastatic HER2-positive breast cancer when combined with capecitabine. The company also develops alisertib, a small molecule inhibitor of aurora kinase A for the treatment of hormone receptor positive breast cancer, triple negative breast cancer, small cell lung cancer, and head and neck cancer. It sells its products through specialty pharmacy and distributor networks. The company has license agreements with Pfizer Inc. for the development, manufacture, and commercialization of neratinib (oral), neratinib (intravenous), PB357, and related compounds, as well as sub-license agreements with Specialised Therapeutics Asia Pte Ltd., Medison Pharma Ltd., Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. Puma Biotechnology, Inc. was founded in 2010 and is headquartered in Los Angeles, California.
OrganisationPuma Biotechnology Inc
Headquarters10880 Wilshire Boulevard, Los Angeles, CA, United States, 90024
IndustryBiotechnology
CEOMr. Alan H. Auerbach
E-voting on sharesClick here to vote

Key Management of Puma Biotechnology Inc

Name

Title

Mr. Mariann Ohanesian

Senior Director of Investor Relations

Ms. Heather Blaber

Senior Vice President of Marketing

Mr. Roger L. Storms

Senior Vice President of Sales

Mr. Alan H. Auerbach

Founder, Chairman, President, CEO & Secretary

Mr. Maximo F. Nougues

CFO & Principal Accounting Officer

Mr. Douglas Hunt B.Sc., FRAPS

Chief Regulatory Affairs, Medical Affairs, Pharmacovigilance & Law Officer

FAQs

What is Puma Biotechnology Inc share price today?

Puma Biotechnology Inc share price today is $7.58 as on at the close of the market. Puma Biotechnology Inc share today touched a day high of $7.73 and a low of $7.46.

What is the 52 week high and 52 week low for Puma Biotechnology Inc share?

Puma Biotechnology Inc share touched a 52 week high of $7.9 on and a 52 week low of $2.75 on . Puma Biotechnology Inc stock price today i.e. is closed at $7.58,which is 4.03% down from its 52 week high and 175.64% up from its 52 week low.

What is Puma Biotechnology Inc's market capitalisation today?

Puma Biotechnology Inc market capitalisation is $0.00T as on .

How to invest in Puma Biotechnology Inc Stock (PBYI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Puma Biotechnology Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Puma Biotechnology Inc Shares that will get you 0.1979 shares as per Puma Biotechnology Inc share price of $7.58 per share as on April 15, 2026 at 1:29 am IST.

What is the minimum amount required to buy Puma Biotechnology Inc Stock (PBYI) from India?

Indian investors can start investing in Puma Biotechnology Inc (PBYI) shares with as little as ₹93.082 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹930.82 in Puma Biotechnology Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Puma Biotechnology Inc share’s latest price of $7.58 as on April 15, 2026 at 1:29 am IST, you will get 1.3193 shares of Puma Biotechnology Inc. Learn more about fractional shares .

What are the returns that Puma Biotechnology Inc has given to Indian investors in the last 5 years?

Puma Biotechnology Inc stock has given -25.71% share price returns and 24.21% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?